Record #3938
A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4(+) T cells in mice
Original paper date
Jul 3, 2012
Original DOI
Country
Institution
Open access
No
Article type
Broad categories
Notes from Retraction Watch
affiliations taken from related articles by authors
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
0
Post-retraction
3
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.2 citations/yr after
— citing papers
Who is still citing this work
Loading…